Page 13 - GlaxoSmithKline Pharmaceuticals AR 2012

9
Another health care project which your Company is supporting through Nirmaya Health
Foundation is in the slums of the dumping grounds in Deonar, Mumbai. Through this project,
your Company is managing a fully-equipped mobile medical van, ensuring that the immediate
health care needs of 30,000 slum dwellers can be assessed and treated, and proper referrals
can be made when necessary. Your company also started safe drinking water project for slum
families and opened a new computer education center for slum children.
During the year, your Company proactively supported four voluntary organizations for cancer
care. This included screening camps to facilitate early detection, treatment, rehabilitation and
palliative care of cancer affected patients from underserved community. Sri Chaitanya Seva
Trust was supported for Cancer screening camps and over 120 camps were conducted,
thereafter more than 10,000 patients were screened for cancer. New initiatives were also
taken to provide complete assistance to cancer patients and their families. Indian Cancer
Society was supported for rehabilitation of 100 cancer patients through vocational training,
employment and nutritious diet. The Bangalore Hospice Trust, Karunashraya was supported
with donation of medicines for care of critically ill cancer patients.
This year marked the beginning of the fifth year of a very successful partnership with Pratham
in Behraich (U.P.) and Jodhpur (Rajasthan). During the year, out of 98 children, 30 children
were repatriated successfully with follow ups on their education. Additionally 30 children will
be enrolled. Digital classes were started to facilitate increased interest in children towards
education, improve quality of education and also to increase the pace of the child’s learning.
Among other initiatives taken during the year was the support to Paraplegic Foundation in
Mumbai for rehabilitation of the severely orthopedically disabled lower socio-economic class
patients. Another new Initiative taken by your company was to run Mid Day Meal Program in
association with ISKON food relief which has contributed to an increase in overall enrolment
in schools. During the year, 70 schools and over 1000 students in Mumbai municipal schools
were supported.
During the year, your Company also supported many projects in the area surrounding Nashik
operations for education of the underprivileged children. The support to the Ashirwad Special
Education School, Delhi which serves mentally challenged children continued. Besides, the
Pushpawati Runtha Kanya Vidhylaya, Shree Ichhyamani Vidhyamandir and Vanita Vikas
Mandal, Nashik, were supported by providing educational material to girls from underprivileged
families. Another project supported was through the Down’s syndrome Care Association,
Nashik for giving Special Toys / Games / Speech / physiotherapy etc. to treat children. Your
Company supported a Computer lab project for Chandak Kanya Vidyalaya and for Avishkar
Education Sanstha.
GSK plc continued its efforts in strengthening immunization in 5 Health Posts of Mumbai
slums with PATH, an international development organization and covered a population of
5 lakh. Through the use of web based MIS system, coverage for immunization increased from
34% to 51% among the eligible children upto 2 years of age.
“The Personal Hygiene and Sanitation Education (PHASE) Programme” supported by GSK plc
was implemented successfully this year as well through Pratham, an NGO working towards
child’s right to education. GSK plc continued its support through donation of Albendazole
tablets to India for the Government Lymphatic Filariasis eradication programme.
(i) Cautionary Note
Certain statements in the “Management Discussion and Analysis” section may be forward-
looking and are stated as required by applicable laws and regulations. Many factors may
affect the actual results, which could be different from what the Directors envisage in terms of
future performance and outlook.
4. Directors
Dr. A. Banerjee resigned as Alternate Director to Mr. S. Harford from 31 st July 2012 and
Mr. V. Narayanan resigned as Director from 9 th November 2012. The Board places on record its
appreciation of the valuable services rendered by Dr. A. Banerjee and Mr. V. Narayanan during
their tenure as Directors and for their contributions to the deliberations of the Board.
The Board of Directors has appointed Ms. Anjali Bansal as Non-Executive Independent Director
with effect from 19 th February 2013, in the casual vacancy caused by the resignation of
Mr. V. Narayanan.
Mr. P. V. Bhide, Mr. M. B. Kapadia and Mr. R. C. Sequeira retire by rotation and, being eligible, offer
themselves for re-appointment.